Free Trial
→ Before you buy SpaceX shares, consider this alternative approach (From Weiss Ratings) (Ad)tc pixel Free PSTV Stock Alerts

Plus Therapeutics (PSTV) Earnings Date, Estimates & Call Transcripts

Plus Therapeutics logo
$5.96 +0.15 (+2.49%)
As of 02:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

Plus Therapeutics Earnings Summary

Plus Therapeutics announced Q1 2026 earnings on May 15, 2026, reporting an EPS of -$1.05, which missed analysts' consensus estimates of -$0.85 by $0.20. Quarterly revenue was reported to be $1.03 million, above the consensus estimate of $0.97 million. With a trailing EPS of -$2.30, Plus Therapeutics' earnings are expected to grow next year, from ($3.66) to ($2.60) per share.

Upcoming Q2
Earnings Date
Aug. 13After Market ClosesEstimated
Consensus EPS
(May. 15)
-$0.85
Actual EPS
(May. 15)
-$1.05 Missed By -$0.20
Actual Revenue
(May. 15)
$1.03M

Q1 2026 Earnings Resources

PSTV Upcoming Earnings

Plus Therapeutics' next earnings date is estimated for Thursday, August 13, 2026, based on past reporting schedules.

Powered by Quartr
Get Plus Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Plus Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

PSTV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PSTV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Plus Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.00-$0.89-$0.95
Q2 20262-$1.00-$0.89-$0.95
Q3 20262-$1.00-$0.89-$0.95
Q4 20262-$1.00-$0.90-$0.95
FY 2026 8 -$4.00 -$3.57 -$3.79
Q1 20271-$0.74-$0.74-$0.74
Q2 20271-$0.74-$0.74-$0.74
Q3 20271-$0.60-$0.60-$0.60
Q4 20271-$0.60-$0.60-$0.60

Plus Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/13/2026
(Estimated)		--------
5/15/2026Q1 2026-$0.8480-$1.05 -$0.2020-$1.05$0.97M$1.03M
3/12/2026Q4 2025-$0.03$6.25+$6.28-$1.23M$1.37M
10/30/2025Q3 2025-$0.50-$1.00 -$0.50-$0.04$1.50M$1.40M
8/14/2025Q2 2025-$2.25-$0.25+$2.00-$0.01$1.08M$1.39M
5/30/2025Q1 2025-$4.25-$14.00 -$9.75-$1.19$1.11M$1.06M
3/27/2025Q4 2024-$12.75-$16.75 -$4.00-$0.67$1.19M$1.80M
8/14/2024Q2 2024--$17.75--$0.71-$1.28M

Data powered by Fiscal.ai.

Plus Therapeutics Earnings - Frequently Asked Questions

Plus Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 13th, 2026 based off last year's report dates. Learn more on PSTV's earnings history.

In the previous quarter, Plus Therapeutics (NASDAQ:PSTV) missed the analysts' consensus estimate of ($0.85) by $0.20 with a reported earnings per share (EPS) of ($1.05). Learn more on analysts' earnings estimate vs. PSTV's actual earnings.

Plus Therapeutics (NASDAQ:PSTV) has a recorded annual revenue of $5.21 million.

Plus Therapeutics (NASDAQ:PSTV) has a recorded net income of -$22.39 million. PSTV has generated -$2.30 earnings per share over the last four quarters.

Plus Therapeutics' earnings are expected to grow from ($3.66) per share to ($2.60) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:PSTV) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel